FGF-16 was found to enhance cancer cells’ migratory capability through upregulating MMPs and repressing E-cadherin, while FGF-9 has been reported to induce N-cadherin and VEGF-A in PC cells [183]. This evidence concerns the gene CDH2 and cancer.